Find in Library
Search millions of books, articles, and more
Indexed Open Access Databases
Na<sub>V</sub>1.8 as Proarrhythmic Target in a Ventricular Cardiac Stem Cell Model
oleh: Nico Hartmann, Maria Knierim, Wiebke Maurer, Nataliya Dybkova, Florian Zeman, Gerd Hasenfuß, Samuel Sossalla, Katrin Streckfuss-Bömeke
Format: | Article |
---|---|
Diterbitkan: | MDPI AG 2024-06-01 |
Deskripsi
The sodium channel Na<sub>V</sub>1.8, encoded by the <i>SCN10A</i> gene, has recently emerged as a potential regulator of cardiac electrophysiology. We have previously shown that Na<sub>V</sub>1.8 contributes to arrhythmogenesis by inducing a persistent Na<sup>+</sup> current (late Na<sup>+</sup> current, I<sub>NaL</sub>) in human atrial and ventricular cardiomyocytes (CM). We now aim to further investigate the contribution of Na<sub>V</sub>1.8 to human ventricular arrhythmogenesis at the CM-specific level using pharmacological inhibition as well as a genetic knockout (KO) of <i>SCN10A</i> in induced pluripotent stem cell CM (iPSC-CM). In functional voltage-clamp experiments, we demonstrate that I<sub>NaL</sub> was significantly reduced in ventricular <i>SCN10A</i>-KO iPSC-CM and in control CM after a specific pharmacological inhibition of Na<sub>V</sub>1.8. In contrast, we did not find any effects on ventricular APD<sub>90</sub>. The frequency of spontaneous sarcoplasmic reticulum Ca<sup>2+</sup> sparks and waves were reduced in <i>SCN10A-</i>KO iPSC-CM and control cells following the pharmacological inhibition of Na<sub>V</sub>1.8. We further analyzed potential triggers of arrhythmias and found reduced delayed afterdepolarizations (DAD) in <i>SCN10A-</i>KO iPSC-CM and after the specific inhibition of Na<sub>V</sub>1.8 in control cells. In conclusion, we show that Na<sub>V</sub>1.8-induced I<sub>NaL</sub> primarily impacts arrhythmogenesis at a subcellular level, with minimal effects on systolic cellular Ca<sup>2+</sup> release. The inhibition or knockout of Na<sub>V</sub>1.8 diminishes proarrhythmic triggers in ventricular CM. In conjunction with our previously published results, this work confirms Na<sub>V</sub>1.8 as a proarrhythmic target that may be useful in an anti-arrhythmic therapeutic strategy.